Lifeist Wellness' subsidiary CannMart has shipped premium cannabis products to Australia. In December 2023, CannMart announced its intention to begin exporting cannabis products to Australia through an agreement with Aura Therapeutics Pty Ltd. ("Aura") to include concentrate and vape carts, bulk flower, and other refined concentrate products in the quickly developing Australian medical cannabis industry.
"The export of cannabis products to Australia underscores CannMart's commitment to expanding its footprint beyond Canadian borders and catering to the evolving needs of medical cannabis patients worldwide," said Daniel Stern, CEO of CannMart. "These high-margin products are poised to make a significant impact in the Australian medical cannabis market, which continues to experience substantial growth and demand for quality cannabis products. The launch of our own Roilty products in Australia also marks a significant milestone in our international expansion strategy."
Australia boasts a large and growing medical cannabis market, with increasing demand for high-quality cannabis products to address various medical conditions. By entering this market, CannMart aims to meet the needs of Australian patients and contribute to the advancement of medical cannabis access and awareness.
For more information:
Lifeist
666 Burrard St #2500
Vancouver, BC V6C 2X8, Canada
Tel.: 888-291-8311
Email: info@lifeist.com
lifeist.com